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New coil concept for endoluminal MR imaging
Initial results in staging of gastric carcinoma in correlation
with Histopathology
Abstract Our aim was to conduct a
prospective study to evaluate staging
accuracy of a new coil concept for
endoluminal magnetic resonance im-
aging (MRI) on ex vivo gastric
carcinomas. Twenty-eight consecutive
patients referred to surgery with a
clinically proven primary gastric ma-
lignancy were included. Surgical
specimens were examined with a
foldable and self-expanding loop coil
(8-cm diameter) at 1.5 Tesla immedi-
ately after total gastrectomy. T1- and
T2-weighted and opposed-phase se-
quences (axial, frontal sections; 3- to
4-mm slice thickness) were acquired.
Investigators blinded to any patient
information analyzed signal intensity
of normal gastric wall, gastric tumor,
and lymph nodes. Findings were
compared with histopathological
staging. On surgical specimens, 2–5
gastric wall layers could be visualized.
All gastric tumors (26 carcinomas,
two lymphomas) were identified on
endoluminal MR data (100%). Overall
accuracy for T staging was 75%
(18/24); sensitivity to detect serosal
involvement was 80% and specificity
89%. N staging correlated in 58%
(14/24) with histopathology (N+ ver-
sus N−). The endoluminal coil con-
cept is feasible and applicable for an
ex vivo setting. Endoluminal MR data
provided sufficient detail for gastric
wall layer differentiation, and there-
fore, identification of T stages in
gastric carcinoma is possible. Further
investigations in in vivo settings
should explore the potential of our coil
concept for endoluminal MR imaging.
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Introduction
Despite the fact that the incidence of gastric cancer is
declining in most Western countries, it remains the second
leading cause of cancer mortality worldwide [1, 2].
Simultaneously, the incidence and prevalence of cancer
arising from the gastric cardia has been increasing since the
1970s [3]. Adenocarcinoma of the esophagogastric junc-
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morphology and anatomical location [4]. Adequate surgi-
cal resection (R0) is the only potentially curative therapy
for eligible patients with gastric carcinoma [4]. In the West,
gastric cancer is often diagnosed at an advanced stage of
disease not eligible for surgery. Fewer than 50% of patients
undergo R0 resection [5, 6]. Recently, new concepts of
multimodal treatment strategies for locally advanced
gastric carcinoma have been investigated [7, 8]. Local
treatment by endoscopic mucosal resection for early gastric
carcinomas is currently being evaluated [9, 10]. Several
phase II and III clinical trials for neoadjuvant chemother-
apy in gastric carcinoma showed its feasibility and safety
[11, 12]. Its purpose is to eliminate or delay systemic
metastasis and reduce micrometastatic spread of disease.
Another benefit is potential reduction of tumor volume in
initially unresectable advanced tumor stages (downstag-
ing), therefore increasing resectability rate. An adequate
treatment strategy, especially in regard to the concept of
neoadjuvantchemotherapy,requirespreciseclinicalstaging
to depict relevant prognostic factors and identify resectable
tumor stages. This also accounts for endoscopically treated
early gastric cancers as well as for adenocarcinomas of the
gastroesophageal (GE) junction since each type of tumor
requires a different surgical approach. Thus, the exact
knowledge of tumor morphology and tumor invasion into
gastric wall is a crucial information for clinical staging.
Up to now, computed tomography (CT) and magnetic
resonance imaging (MRI) have not provided the spatial
resolution to fulfill this requirement with sufficient accuracy
[1, 13–16]. Results for staging accuracy of endoscopic
ultrasound (EUS) also seem to be improvable [17–19]. The
main aspect of gastric wall differentiation is spatial resolu-
tion. By using endoluminal radiofrequency (RF) coils for
MRI, image quality and spatial resolution can be enhanced.
MRI provides superior soft tissue contrast, which makes it
useful for tumor invasion detection; furthermore, informa-
tion not obtainable by other imaging modalities is acquired.
VariousauthorsreportedtheuseofendoluminalRFcoilsasa
diagnostic and staging tool in gastrointestinal diseases and
rectal and prostate cancer [20–27]. A major problem with
endoluminal RF coils is placement close to the region of
interest and depth of visualization. Our approach uses a
foldable and afterward self-expanding loop coil design
(8-cm diameter), which enhances spatial resolution and
depth of visualization The aim of our study was to assess
normal gastric wall architecture and signal intensity (SI) on
endoluminalMRIaswellassignalintensityandappearance
of gastric carcinomas and their related lymph nodes.
Subsequently, we used endoluminal MRI as staging
modality on ex vivo gastric carcinomas. Findings were
compared with histopathological staging.
Materials and methods
Patients
A prospective study was conducted on patients with gastric
malignancies referred for total gastrectomy to the surgery
department of our university hospital. They were included
in the study if the lesion was identified by EUS or CT
suggesting a gastric carcinoma or if histological workup of
biopsies confirmed the diagnosis. The study protocol was
approved by the institutional review board, and informed
consent was acquired from each patient prior to surgery.
We investigated 28 consecutive patients, 11 women and 17
men (age range 46–87, median 67 years). Tumors were
located at the cardiac region in 11 cases, the fundal area in
two, the corpus in six, and the antropyloric area in nine.
Immediately after surgery, gastrectomy specimens were
taken to the MR suite to conduct the examination within a
time frame of 2–3 h (Fig. 1). Specimens where then sent to
histopathology unchanged from the procedure.
Endoluminal RF coil
The endoluminal RF coil (patent issued 10/2005, German
Patent and Trade Mark Office, No: 10127850.0–35,
Grenacheret al.), developed in collaboration with Fraunhofer
Institute for Biomedical Engineering (IBMT, St. Ingbert,
Germany) consists of a foldable and self-expanding receiver
loop (8-cm diameter). It is coated with a biocompatible
material (silicone) to prevent direct contact of the wire with
Fig. 1 Flowchart of study design
2402stomach tissue [29]. The flexible characteristics of the shape
memory metal (nitinol) used allow passage through the
instrument channel (13-mm diameter) of a speciallydesigned
MR-compatible endoscope. The MR-compatible endoscope
was not used in this study and is described elsewhere, but it is
mentioned in this context because RF coil design is reflected
by the specifications of the endoscope. A nonferromagnetic
tuningboxconnectstheRFcoilviaastandardinterfacewitha
1.5-Tesla MRI scanner (Symphony, Siemens, Erlangen,
Germany), which was used in this study. Gastrectomy
specimens were placed in a container with 3–4 l of 0.9%
sodium chloride solution to ensure good contrast with gastric
tissue and adequate expansion of gastric folds. The loop of
t h eR Fc o i lw asp la c e do nt h em u c o s as id eo fth etu m o r .A f t e r
the tumor was located with a scout sequence, images where
acquiredin axialand frontalsectionsof3-to4-mmthickness.
Scanning was performed with T1- and T2-weighted and
opposed-phase sequences (Table 1).
Image evaluation
Image data were read on certified diagnostic work stations
independently by two board-certified radiologists with 10
and 12 years of experience, respectively, and one board-
certified surgeon with 8 years of experience in endoscopic
ultrasound on gastric carcinomas. Investigators were
blinded to any clinical information as well as patient
identification. After separate reading, a discussion was held
about the quality of data and unique features of the case.
Additionally, final agreement was achieved if disagreement
on tumor stage had initially occurred. With respect to the
unique imaging technique, the resolution and detail of
image data a consensus staging was reasonable. Radiolog-
ical and histopathological classification of the tumor was
done according to the Tumor Node Metastisis (TNM)
staging system of the Union Internationale Contre le
Cancer (UICC) [30]. Determination of tumor stage was
done as follows:
1. T1: tumor invasion of the lamina propria of mucosa or
invasion of submucosa, wall thickening, and signal
intensity changes confined to these layers.
2. T2: tumor invasion extended to the muscularis propria,
and additional thickening through gastric layers with
signal intensity changes showing either a homoge-
neous or inhomogeneous lesion without serosal
abnormalities. If invasion extended beyond muscularis
propria into an adjacent fat tissue plane without serosal
infiltration, it was considered as T2.
3. T3: tumor invasion of mucosa, submucosa, and
muscularis propria, with infiltration of the serosa or
changes in signal intensity presenting with micronod-
ular strands as growth into extraserosal fat tissue.
4. T4: tumor invasion into adjacent organs or structures
clearly presenting as contiguous tumor extension or a
mass with similar signal intensity as the gastric tumor.
N staging was done counting the lymph nodes detectable
on MRI, regarding them as pathologic due to their signal
intensity. Since gastrectomy samples varied in lymph node
content due to surgical technique and extension of the
gastrectomy not comparable to an in vivo situation, N
factor was graded into N+ for positive findings of lymph
nodes and into N− for absence of lymph nodes. In each
case, normal gastric wall features were assessed. Signal
intensities of the mucosa, submucosa, muscularis propria,
and serosa or subserosa were recorded, as well as the
amount of layers in which the normal gastric wall could be
Table 1 Imaging sequence parameters
Sequence Repetition time
(TR)
Echo time
(TE)
Acquisitions Slice thickness
(mm)
Matrix Field of view
(FOV) (mm)
Pixel size
(mm)
T1-weighted TSE 551 14 2 4 512x512 200 0.39x0.39
T2-weighted TSE 3,520 70 2 3 1024x1024 220 0.21x0.21
T2-weighted GRE 1,050 35 1 3 512x512 220 0.43x0.43
T1-weighted GRE
opposed phase
187 7 4 3 256x265 220 0.86x0.86
TSE turbo spin echo, GRE gradient recalled echo
Table 2 Comparison of histologic with endoluminal findings without knowledge of tumor region
Endoluminal magnetic resonance imaging (MRI) findings
Histologic findings T1 T2 T3 T4 Total (n=24)
T 1 121– 4
T 2 177– 15
T3 – 12– 3
T4 ––11 2
2403differentiated into. A score system from 1 to 5 (1=poor;
5=very good) was used for several study items to weigh the
power of their findings. Each sequence, for example, was
rated for image quality on a range from 1 to 5, representing
insufficient to very good. Signal intensity and morphology
of the gastric tumors and demarcation to normal gastric
wall were used to describe characteristics of tumor
presentation. The lesion was identified by irregular
architecture of gastric wall, abnormal thickening, and
change in signal intensity of gastric wall layers, which
usually present with sharp and clear demarcation into three
to five different layers with distinct signal intensities and
thickness. Tumor size was not measured, as it does not
influence T staging or provide further information. Histo-
pathology was considered the gold standard, and radiolog-
ical data where compared with its results.
All data are presented as absolute numbers and relatively
as percentages. Concordance of histopathological results
and radiological findings are reported as overall accuracy.
Sensitivity, specificity, and accuracy for T factor, N+/−
factor are provided. Detection rate of serous membrane
invasion or the differentiation between T2 and T3 stages
was assessed, as it defines advanced stages of disease.
Ninety-five percent confidence intervals (CI) are given if
statistically applicable.
Results
The setup of our study proved to be feasible, as shown
elsewhere [29]. Two cases were not included because of
insufficient image quality. Histopathology found 26
carcinomas (15 adenocarcinomas, nine signet cell carcino-
mas, two mixed type carcinomas) and two gastric
lymphomas. Four tumors were classified as pT1, 15 as
pT2, 3 as pT3, and 2 as pT4. Gastric lymphomas were
excluded from the study although they where detected as
such in both cases (100%).
Gastric tumor staging
In 24 (100%) cases, the tumor was identified. Initially 46%
(11/24) of T stages were staged correctly; 1/4 of pT1
tumors, 7/15 of pT2 tumors, 2/3 of pT3 tumors, and 1/2 of
pT4 tumors were classified correctly (Table 2). Interpre-
tation of image data was done without knowledge of tumor
location in respect to the gastric region, such as cardia,
fundus, corpus, or antrum, as it would be possible on an in
vivo setting such as endoscopy or CT. In a second reading
session, the interpreters were informed about the gastric
region of the primary tumor for each case. In knowledge of
gastric region, six, first as T3 classified carcinomas of the
cardia, were correctly staged as pT2 and one, first as T3
classified tumor (cardia), was correctly identified as pT4
(Table 3). This gives an overall accuracy of 75% (18/24)±
–17.32 (CI) (Table 4). The mean score for T-factor staging
was 3.54 (range 2–5). Sensitivity, specificity, and accuracy
for detecting serosal involvement was 80%±16.00, 89%±
12.27, and 88%±13.23, with a mean score of 4.5 (range 3–
5; Table 5). Overstaging occurred in 4/24, three pT1 tumors
were classified as T2 or T3 stages, and one pT2 tumor was
identified as T3 stage (Table 6). In this case, the tumor
replaced all gastric wall layers and invaded perigastric fat
tissue but did not infiltrate the serous membrane.
Insufficient separation of gastric wall layers and the
presence of abnormal signal intensities most likely desmo-
plastic reactions or peritumor inflammation were identified
retrospectively as reasons for overstaging of pT1 tumors.
Two tumors (pT2, pT3) were understaged as T1 and T2
stage. One case was a diffuse type pT2 adenocarcinoma
Table 3 Comparison of histologic findings with endoluminal findings acquired with knowledge of tumor region
Endoluminal magnetic resonance imaging (MRI) findings
Histologic findings T1 T2 T3 T4 Total (n=24)
T 1 121— 4
T2 1 13 1 — 15
T3 – 12– 3
T4 –––22
Table 4 Sensitivity, specificity, and accuracy for each T stage; overstaging and understaging rates
T1 T2 T3 T4 Overall
Sensitivity 1/4 13/15 2/3 2/2 –
Specificity 19/20 6/9 19/21 22/22 –
Accuracy 20/24 19/24 21/ 24 24/24 18/24
Overstaging 3/4 1/15 –– 4/24
Understaging – 1/15 1/3 – 2/24
2404with disseminated infiltration into the muscularis propria,
which is not visualized and thus presented as T1 stage.
Nodal involvement
Lymph node detection resulted in N+ for detected lymph
nodes in 17 cases with N− in 7 cases. Sensitivity for
detecting N+ was 71%±18.22, specificity 29%±18.07, and
accuracy 58%±19.72. This reflects the limitation of the
study design. Ex vivo gastrectomy specimens do not
provide the same quantity of lymph nodes as pathological
workup. The mean score rating N factor staging was 4.4
(range 2–5).
Image analysis
Separation of gastric wall layers ranged from a minimum of
two visible layers to five distinct visible layers (mean 3.10)
in 51 analyzed sequences: 21 T1-weighted and 27 T2-
weighted sequences and three opposed-phase sequences
(Table 6). T2-weighted sequences depicted an average of
3.37 gastric wall layers; T1-weighted sequences 2.76.
Mean score for image quality of the sequences used was
3.88 (range 2–5), with 4.11 for T2- and 3.62 for T1-
weighted sequences. Image analysis revealed that in four
out of six incorrectly staged T factors, tumors were
described as inhomogeneous or diffuse concerning demar-
cation to normal gastric wall. This may be one reason for
misinterpretation of T factor. Signal intensity of the mucosa
for T1-weighted sequences was mostly classified as
hyperintense; for T2-weighted, it was intermediate. Sub-
mucosa, muscularis propria, and serosa or subserosa
presented with hypointense, intermediate, hypointense SI
for T1-weighted; hyperintense, intermediate, hypointense
for T2-weighted sequences (Table 6). Lymph node and
tumor appearance correlated in 86%±9.9 (44/51 se-
quences), with intermediate SI for T1- and T2-weighted
sequences. Out of eight sequences without correlation in
lymph node and tumor SI, two sequences showed a
homogeneous tumor in T1-weighted and an inhomogeneous
lesion in T2-weighted images (Fig. 3). In threeopposed-phase
sequences, lymph nodes (hypointense) showed different
signal intensity than the primary tumor (intermediate). T2-
weighted sequences (Table 4) visualized more gastric wall
layers and provided the interpreter with a better demarcation
of tumor volume from normal gastric wall than did T1. T1-
weighted sequences showed a better delineation and contrast
of lymph nodes in adjacent structures (Fig. 2).
Discussion
Endoluminal MRI has been used by various groups to asses
its ability for locoregional imaging of esophageal and
gastrointestinal disease. The first group [20, 31]t o
introduce an MR endoscope reported promising results
for the diagnosis of gastrointestinal diseases and pointed
out limitations of their design [20, 31]. Image quality of
endoluminal MRI was not as clear as those acquired by
EUS, and their success rate of obtaining clear images of the
stomach was low (58%) [20]. Although their study
achieved 89% for T-staging accuracy, its patient collective
consisted mainly of advanced gastric carcinomas (T3, T4).
Other authors reported the use of an MR endoscope with a
similar design [21, 28, 32], sharing the incorporation of the
RF coil with 10×30 and 10×47 mm into the tip of the MR
endoscope. This is a useful design for imaging at the
esophagus, where both groups showed good results in
staging esophageal cancer [20, 28]. The small cylindrical
RF coil design implemented in the tip of the MR endoscope
may be a reason for problems in obtaining sufficient
images in the stomach. Our approach using an insertable
and self-expandable RF coil (8-cm diameter), independent
from the MR endoscope, seems to be more suitable for
imaging of the stomach by providing enhanced depth of
Table 5 Results for serosal invasion detection
Evaluation of serosal invasion
Sensitivity 4/5
Specificity 17/19
Accuracy 21/24
False positive 2
Table 6 Signal intensities of gastric wall layers on T1-weighted,
T2-weighted, and opposed-phase imaging from inside to outside
T1 imaging
(n=21)
a
T2 imaging
(n=27)
a
Opposed phase
imaging (n=3)
a
Two layers
(n=7)
b
High ––
Intermediate
Three layers
(n=33)
b
High Intermediate High
Low High Low
Intermediate Intermediate High
Four layers
(n=10)
b
High Intermediate –
Low Low
Intermediate Intermediate
Low Low
five layers
(n=1)*
– Intermediate –
High
Intermediate
Low
Intermediate
aNumber of sequences analyzed
bNumber of sequences with n layers
2405visualization. In 93%, sufficient image data was obtained.
Detection of resectable lesions can only be accomplished
by exact knowledge of tumor invasion in relation to gastric
wall layers. New multimodal treatment strategies require
the information of tumor stage, as it defines enrollment into
neoadjuvant therapy approach. Clinical staging based on
imaging studies can provide important information for
adequate therapy decision if they fulfill this requirement.
Gastric wall differentiation and identification is essential
for accurate staging of gastric malignancies.
Our approach can depict between two to five gastric wall
layers and therefore deliver sufficient detail as basis for
tumor invasion detection. Signal intensities of gastric
layers assessed in our study correspond mainly to those
reported previously by other authors [20, 33, 34]. Visual-
ization of the serosa layer remains a problem in all
published studies with MRI or endoluminal MRI on gastric
wall. Some authors investigated ex vivo gastrectomy
specimen with a 1.0-Tesla MRI device and were able to
differentiate up to five different gastric layers, but visual-
ization of the serosa or subserosa was not achieved [35].
One reported study used a 2.4-Tesla MRI system and
failed, as did another study with a 4.7-Tesla MRI system, to
visualize serosa or subserosa as a distinct layer [34, 36].
One work group reported possible identification of serosa
or subserosa on gastrectomy specimens after fixation with
formalin [33]. With the use of a 1.5-Tesla MRI device and a
4-cm-diameter loop coil, muscularis propria and serosa or
subserosa showed isointense signal intensities but were
outlined by subserosal fat tissue with contrasting signal
intensity. The results were confirmed by another work
group using a similar setup [37]. Identification of the serosa
is necessary to securely differentiate between T2- and T3-
stage gastric carcinoma. Although a detection rate of 88%
for serosal involvement was achieved in this study, serosa
as a single gastric wall layer was not clearly visualized. In
seven cases with four to five visible gastric layers, a thin
outer layer on T2-weighted sequences was detected and
could possibly be identified as serosa or subserosa with
subserosal fat tissue. This finding was inconsistent and
varied in different T-stage carcinomas. This may be
because of isointense signal intensity of muscularis
mucosae and serosa or subserosa or the fact that the
thickness of the serosa layer is not sufficient for secure
identification [38]. It is not certain whether tumor invasion
into or close to the serosa or subserosa layer changes its
signal intensity presentation. Indirect detection by subse-
rosal fat tissue seems possible, but in our experience, there
is some variance in the thickness of subserosal fat tissue in
gastric carcinoma specimens. One reason for this could be
tumor cachexia.
An interesting learning point is reflected by the results of
Tstaging. Knowledge of the gastric region where the tumor
is located is important since T staging of the stomach
dependsonthegastric region.Tumors ofthe cardiaandpart
of the fundus region where a serosal layer is missing are
considered T2 whereas they would be T3 in other gastric
regions. The study setup was intended to be as close as
possible to a future in vivo setting with an MR endoscope,
but tumor location and gastric region cannot be read on
image data from gastrectomy specimens. An in vivo setting
would enable investigators to acquire this information.
Fig. 3a, b T2 signet cell tumor of the cardia region (diffuse type of
Lauren classification, white arrowhead) on T1-weighted (a) and T2-
weighted imaging (b). The extent of tumor mass and the diffuse
infiltration into gastric wall is better visualized on T2-weighted
images due to the mucinous character of the tumor (black
arrowheads). The tumor appears more homogeneous on T1-
weigthed images (a). (*) marks the position of the receiver coil
Fig. 2a, b Two consecutive T2-weighted images (a, b)o faT 1
early gastric carcinoma (white arrowheads), well differentiated
(intestinal type of Lauren classification), located at the subcardial
region. Lymph nodes in adjacent fat tissue with a high signal
intensity (white arrows) are visualized. Morphology of normal
gastric wall is pointed out by open arrows. (*) marks the position of
the receiver coil
2406After providing the tumors’ gastric region, T staging
accuracy improved to 75%. Thus, the gastric region of
tumor location is an important fact for adequate staging of
tumor invasion. While this study used an ex vivo model
of gastric carcinomas and the amount of patients included
could be higher, the entire range of T factors for gastric
carcinomas is covered. Another limitation of this study is
the missing congruence of lymph nodes present in the
gastrectomy specimens due to surgical technique to those
available for histopathology. This is reflected by N-factor
s t a g i n gr e s u l t s .A ni nv i v os e t t i n gs ho u l db em o r ea c c u r a t e
but poses new problems, such as motion artefacts due to
patient or endoscope movement. Modern rapid MRI
sequences and spasmolytic agents may be able to over-
come theseobstacles in an in vivo setting, butthis is a goal
forfuturestudies.Itisimportanttopointoutpitfallsofthis
imaging technique, as overstaging is a problem in many
imaging modalities. Peritumor inflammation, micronodu-
lar affection of the serosal membrane, and diffuse-type
gastric carcinoma were retrospectively identified as
reasons for misinterpretation of tumor invasion. Over-
staging occurred in 17%, with three T1 tumors not
correctly classified. This is encouraging since all T1
tumors were detected as tumors but in two cases were
classified as T2 tumors and one as T3. Only one
incorrectly classified T2 tumorcontributed to overstaging.
This indicates that overstaging was not a problem of
differentiation between T2 and T3 stages of disease.
It is necessary to focus on T1 carcinomas, as experience
with T1 carcinomas in imaging modalities in Western
countries is low due to the fact that most gastric cancers
are diagnosed at an advanced stage. It is important to learn
more about signal intensity and morphologic presentation
of early gastric carcinomas on endoluminal MRI to
improve detection rate. Endoluminal MR imaging pro-
vides enough detail to visualize a T1 tumor (Fig. 2).
Endoscopic mucosal resection as one treatment option for
early gastric carcinoma requires an imaging method that is
able to visualize and identify these stages securely and
provide information that is observer independent. Further
studies should include a larger quantity of early stages of
gastric carcinomas to analyze accuracy potential of
endoluminal MRI. MR images provide information not
obtainable by other imaging modalities. A gastric tumor
can present with different appearances on T1-weighted
imaging than on a T2-weighted imaging (Fig. 3). Depth of
visualization of a method is essential for staging a gastric
tumor, assessing its depth of invasion into gastric wall and
into adjacent organs and structures, as well as depicting
involved lymph nodes. Our image data can provide
detailed information about gastric wall invasion as well as
organ invasion (Figs. 2 and 4).
In this study, we have shown that our concept is
functional and feasible for MRI of the stomach, and staging
results comparable with other imaging modalities were
achieved. Endoluminal MRI in combination with conven-
tional MRI could assess local and regional imaging in one
session, giving accurate information about local staging
and metastatic spread of disease. Secondary contrast media
should be evaluated for its use in improving gastric wall
layer discrimination and identification as well as tumor
demarcation. Additional studies are needed to assess the
clinical feasibility of this coil concept in vivo for imaging
of the upper gastrointestinal tract. High-resolution imaging
of the pancreas could be another possible application.
Today, most tumors of the stomach and esophagus are
staged by conventional methods, such as endoscopy, EUS,
or CT. Future prospects of endoscopic MRI may be limited
to certain tumor entities, such as early or advanced
carcinomas, but it could be able to answer additional
specific clinical questions for relevant therapy decisions.
Summary Endoluminal MRI with the coil concept is
feasible and applicable. T staging of ex vivo gastric
carcinomas is possible. Results for T-factor staging are
preliminary but promising, as they reflect the first
experience with this technique. Image quality and resolu-
tion obtained with the endoluminal RF coil are convincing
for future use in gastrointestinal imaging. Limitations of
this study include missing congruence in quantity of
lymph nodes for N staging, a limited amount of some T-
stage gastric carcinomas, and the ex vivo setting. Taking
the limitations into account, the coil design should be
investigated in an in vivo setting after assessing safety
Fig. 4a, b T4 gastric tumor (intestinal type of Lauren classification,
open arrows) on T2-weighted images of the same plane. Transition
of normal gastric wall into tumor mass (white arrows). Pancreas
(white arrowheads) adjacent to the gastric wall demonstrates
depth of visualization (a). Tumor invasion into pancreas (black
arrowheads)( b)
2407aspects to evaluate the prospects given by the ex vivo
results. The clinical potential may be limited by providing
a staging tool for certain tumor entities. With more
experience in endoluminal MRI and interpretation of
endoluminal image data, its use could be extended toward
other fields in gastrointestinal imaging.
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